ALPHARETTA, Ga., Sept. 10, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that its orthoPACE® device has received official regulatory approval from the South Korean Ministry of Food and Drug Safety (MFDS – South Korea). With this approval, SANUWAVE will begin commercializing orthoPACE in South Korea. The orthoPACE device has been proven safe and effective for the treatment of chronic tendonitis and joint pain in the musculoskeletal system. orthoPACE treatments have been especially effective in treating plantar fasciitis and tendonitis, which commonly require surgery.
Help employers find you! Check out all the jobs and post your resume.
